Bernard Lerer

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Neurorestorative Properties of Ibogaine: Linking Multi-Receptor Affinities to Remyelination and Metabolic Restoration.

Neurorestorative Properties of Ibogaine: Linking Multi-Receptor Affinities to Remyelination and Metabolic Restoration.

Journal: Acta neuropsychiatrica
Published: February 12, 2026

Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration.

Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration.

Journal: Acta neuropsychiatrica
Published: February 12, 2026

DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolism.

DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolism.

Journal: Molecular metabolism
Published: July 10, 2025

Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".

Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".

Journal: Molecular psychiatry
Published: June 10, 2025

Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration.

Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration.

Journal: Translational psychiatry
Published: April 16, 2025

Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatment.

Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatment.

Journal: The international journal of neuropsychopharmacology
Published: January 08, 2025

Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming.

Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming.

Journal: bioRxiv : the preprint server for biology
Published: July 09, 2024

Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming.

Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming.

Journal: Molecular psychiatry
Published: June 25, 2024

Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.

Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators.

Journal: Frontiers in pharmacology
Published: February 25, 2024

Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.

Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.

Journal: Molecular psychiatry
Published: July 09, 2023

Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.

Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain.

Journal: Molecular psychiatry
Published: July 06, 2023

Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].

Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].

Journal: Cancer letters
Published: April 27, 2023
Showing 1-12 of 53

Last Updated: 09/26/2026